Literature DB >> 29339948

Update on Functional Heartburn.

Takahisa Yamasaki1, Jessica O'Neil1, Ronnie Fass1.   

Abstract

The definition of functional heartburn has been refined over the years. It is currently described, based upon Rome IV criteria, as typical heartburn symptoms in the presence of normal upper endoscopy findings (including normal biopsies), normal esophageal pH testing, and a negative association between symptoms and reflux events. Functional heartburn is very common, affecting women more than men, and with reflux hypersensitivity makes up the majority of heartburn patients who fail twice-daily proton pump inhibitor therapy. These disorders overlap with other functional gastrointestinal disorders and are often accompanied by psychological comorbidities. Diagnosis is made by using endoscopy with esophageal biopsies, wireless pH capsule, pH-impedance monitoring, and high-resolution esophageal manometry. Additional diagnostic tools that may be of value include magnification endoscopy, chromoendoscopy, narrow-band imaging, autofluorescence imaging, mucosal impedance, impedance baseline values, and histopathology scores. Functional heartburn is primarily treated with neuromodulators. Psychological intervention and complementary and alternative medicine may also play important roles in the treatment of these patients.

Entities:  

Keywords:  Heartburn; esophagus; pH testing; proton pump inhibitor; upper endoscopy

Year:  2017        PMID: 29339948      PMCID: PMC5763558     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  73 in total

1.  Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure.

Authors:  Renato Caviglia; Mentore Ribolsi; Nicola Maggiano; Armando M Gabbrielli; Sara Emerenziani; Michele Pier Luca Guarino; Simone Carotti; Fortunéé Irene Habib; Carla Rabitti; Michele Cicala
Journal:  Am J Gastroenterol       Date:  2005-03       Impact factor: 10.864

2.  Esophageal mucosal impedance: is it time to forgo prolonged gastroesophageal reflux recordings?

Authors:  Ronnie Fass
Journal:  Gastroenterology       Date:  2014-12-18       Impact factor: 22.682

3.  Non-erosive reflux disease (NERD)--acid reflux and symptom patterns.

Authors:  S D Martinez; I B Malagon; H S Garewal; H Cui; R Fass
Journal:  Aliment Pharmacol Ther       Date:  2003-02-15       Impact factor: 8.171

4.  On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis--a placebo-controlled randomized trial.

Authors:  T Lind; T Havelund; L Lundell; H Glise; K Lauritsen; S A Pedersen; O Anker-Hansen; A Stubberöd; G Eriksson; R Carlsson; O Junghard
Journal:  Aliment Pharmacol Ther       Date:  1999-07       Impact factor: 8.171

5.  Psychological factors influence the overlap syndrome in functional gastrointestinal disorders and their effect on quality of life among firefighters in South Korea.

Authors:  Seung-Ho Jang; Han-Seung Ryu; Suck-Chei Choi; Sang-Yeol Lee
Journal:  J Dig Dis       Date:  2016-04       Impact factor: 2.325

6.  Mucosal impedance discriminates GERD from non-GERD conditions.

Authors:  Fehmi Ates; Elif Saritas Yuksel; Tina Higginbotham; James C Slaughter; Jerry Mabary; Robert T Kavitt; C Gaelyn Garrett; David Francis; Michael F Vaezi
Journal:  Gastroenterology       Date:  2014-10-16       Impact factor: 22.682

7.  Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease.

Authors:  Frank Zerbib; Kafia Belhocine; Mireille Simon; Maylis Capdepont; François Mion; Stanislas Bruley des Varannes; Jean-Paul Galmiche
Journal:  Gut       Date:  2011-10-13       Impact factor: 23.059

8.  Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus.

Authors:  S Emerenziani; D Sifrim; F I Habib; M Ribolsi; M P L Guarino; M Rizzi; R Caviglia; T Petitti; M Cicala
Journal:  Gut       Date:  2007-08-31       Impact factor: 23.059

9.  Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn.

Authors:  Arne Kandulski; Jochen Weigt; Carlos Caro; Doerthe Jechorek; Thomas Wex; Peter Malfertheiner
Journal:  Clin Gastroenterol Hepatol       Date:  2014-12-09       Impact factor: 11.382

10.  Omeprazole as a diagnostic tool in gastroesophageal reflux disease.

Authors:  B E Schenk; E J Kuipers; E C Klinkenberg-Knol; H P Festen; E H Jansen; H A Tuynman; M Schrijver; L A Dieleman; S G Meuwissen
Journal:  Am J Gastroenterol       Date:  1997-11       Impact factor: 10.864

View more
  3 in total

1.  Treatment of Refractory Gastroesophageal Reflux Disease.

Authors:  Rishi D Naik; Matthew H Meyers; Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-04

Review 2.  The Proton Pump Inhibitor Nonresponder: a Behavioral Approach to Improvement and Wellness.

Authors:  Megan E Riehl; Joan W Chen
Journal:  Curr Gastroenterol Rep       Date:  2018-06-09

Review 3.  Alternative Treatments for Minor GI Ailments.

Authors:  A K Mohiuddin
Journal:  Innov Pharm       Date:  2019-07-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.